Sanofi Consumer Healthcare Share Price Today | Stock Price & Sanofi Consumer Healthcare Share Screener
As of October 5, 2026, the live Sanofi Consumer Healthcare share price (NSE: SANOFICONR) is ₹3,752.70 on NSE and ₹3,748.15 on BSE, down 0.91% from the previous close, with shares trading between ₹3,729.20 and ₹3,787.90 in today's trading session, and a 52-week range of ₹3,752.70–₹5,026.80. Check SANOFICONR 52-week performance for the annual price range and momentum. Use the Sanofi Consumer Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sanofi Consumer Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹969 and net income of ₹266, with EBITDA of ₹372, an operating margin of 37.0% and a profit margin of 27.5%.
Sanofi Consumer Healthcare Share Price Chart
Track the current stock price of Sanofi Consumer Healthcare with an interactive chart. Analyse SANOFICONR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sanofi Consumer Healthcare stock quote in one place.
The quote of ₹3,752.70 sits between the 52-week low of ₹3,752.70 and the 52-week high of ₹5,026.80, and the latest session moved -0.91% from the previous close.
Sanofi Consumer Healthcare Company Profile - Fundamental Screener
Screen Sanofi Consumer Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANOFICONR shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0UOS01011.
Company Details
Classification
Identifiers and Leadership
Sanofi Consumer Healthcare Balance Sheet Screener
Screen SANOFICONR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹547, up from ₹431 in 2024.
Latest statistics put total assets at ₹547 and shareholder funds at ₹384, with a leverage ratio of 0.07.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
Assets |
|||
| Total Assets | 547 | 431 | 345 |
| Current Assets | 494 | 392 | 335 |
| Fixed Assets | 36 | 29 | 5 |
Liabilities |
|||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 35 | 28 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 |
Shareholders' Equity |
|||
| Total Equity | 384 | 273 | 208 |
| Share Capital | 23 | 23 | 2 |
| Reserves & Surplus | 361 | 250 | 183 |
Sanofi Consumer Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Sanofi Consumer Healthcare income statement and profit fundamentals. Analyze SANOFICONR quarterly results. Sanofi Consumer Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹969 and net profit was ₹266, equal to earnings per unit of ₹115.50, at an operating margin of 37%.
In that period expenses were ₹597, interest cost ₹2 and tax ₹94. The next period listed, 2025-March, shows revenue of ₹897 and net profit of ₹240.
| Item | None-None | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
Revenue and Expenses | ||||
| Revenue | 969 | 897 | 738 | 560 |
| Expenses | 597 | 569 | 454 | 337 |
Operating Costs and Margins | ||||
| EBITDA | 372 | 327 | 284 | 223 |
| Operating Profit % | 37.00% | 35.00% | 37.00% | 39.00% |
| Depreciation | 13 | 12 | 5 | 2 |
| Interest | 2 | 2 | 4 | 0 |
Profit and Earnings | ||||
| Profit Before Tax | 357 | 320 | 247 | 219 |
| Tax | 94 | 80 | 66 | 54 |
| Net Profit | 266 | 240 | 181 | 165 |
| EPS | 115.50 | 104.27 | 78.59 | 71.60 |
Sanofi Consumer Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen SANOFICONR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹175, and net cash flow was an inflow of ₹48.
Over the same period, investing activities provided ₹8 and financing activities used ₹135.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
Cash from Operations and Investing | |||
| Operating Activities | 175 | 439 | 0 |
| Investing Activities | 8 | 2 | 0 |
Financing and Net Cash | |||
| Financing Activities | -135 | -116 | 2 |
| Net Cash Flow | 48 | 325 | 2 |
Sanofi Consumer Healthcare Shareholding Pattern Screener
See Sanofi Consumer Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Sanofi Consumer Healthcare promoter holding and ownership changes for SANOFICONR on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 71.27%, foreign institutions 2.76%, domestic institutions 17.57% and the public 6.26%, spread across 48,418 shareholders.
The shareholder count was 48,418 in 2026-Mar, compared with 47,511 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 71.27% | 71.27% | 60.40% | 71.27% | 71.27% | 71.27% | 60.40% | 60.40% |
Institutional Investors | ||||||||
| FII Holding | 2.76% | 2.60% | 4.53% | 3.24% | 2.94% | 2.83% | 0.00% | 5.22% |
| DII Holding | 17.57% | 17.86% | 25.48% | 16.89% | 17.21% | 17.33% | 20.87% | 24.03% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.26% | 6.18% | 6.58% | 6.30% | 6.26% | 6.25% | 7.71% | 7.53% |
| Other Holding | 2.14% | 2.10% | 3.01% | 2.30% | 2.32% | 2.31% | 11.03% | 2.83% |
| Shareholder Count | 48,418 | 47,511 | 51,859 | 49,632 | 48,808 | 48,075 | 61,091 | 61,091 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sanofi Consumer Healthcare. Sanofi Consumer Healthcare dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹75.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹75.00 and ₹55.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹75.00 | 1.74% |
| 2024-March | ₹55.00 | 1.14% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sanofi Consumer Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Sanofi Consumer Healthcare stock. Check SANOFICONR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 4 indices, including BSE INDEX BSE HC.
Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250, NIFTY TOTAL MKT.
Complete Index List
Sanofi Consumer Healthcare Market Events Screener - Corporate Actions
Get Sanofi Consumer Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sanofi Consumer Healthcare stock events that may affect SANOFICONR share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 28, 2026, with a record date of July 28, 2026.
It is followed by Annual General Meeting dated June 26, 2026 and Dividend dated June 19, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-28 | 2026-07-28 | Quarterly Result Announcement | NA | 2.37% |
| 2026-06-26 | 2026-06-26 | Annual General Meeting | NA | -0.48% |
| 2026-06-19 | 2026-06-19 | Dividend | ₹ 75.00 /share | 23.74% |
| 2026-04-28 | 2026-04-28 | Quarterly Result Announcement | NA | 1.44% |
| 2026-02-25 | 2026-02-25 | Quarterly Result Announcement | NA | -4.76% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -5.69% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -2.10% |
| 2025-05-05 | 2025-05-05 | Annual General Meeting | NA | 3.98% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 0.05% |
| 2025-04-17 | 2025-04-17 | Dividend | ₹ 55.00 /share | 5.10% |
| 2025-02-20 | 2025-02-20 | Quarterly Result Announcement | NA | 0.62% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 0.78% |
Sanofi Consumer Healthcare Competitors Screener - Peer Stocks Comparison
Screen SANOFICONR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 34.02 |
Sanofi Consumer Healthcare Company Announcements - News & Reports Screener
Screen SANOFICONR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 4, 2026.
The next most recent announcements are dated July 30, 2026 and July 28, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-04 | Closure of Trading Window | - |
| 2026-07-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-28 | Results - Financial Results For June 30 2026 | - |
| 2026-07-28 | Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 28Th July 2026 | - |
| 2026-07-22 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026. | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-29 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
| 2026-06-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-06-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-04 | Shareholder Meeting - AGM On 26Th June 2026 | - |
| 2026-06-04 | Shareholder Meeting - AGM On 26Th June 2026 | - |
| 2026-06-04 | Reg. 34 (1) Annual Report. | - |
| 2026-06-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Intimation Of Record Date For Payment Of Final Dividend For FY 2025 | - |
| 2026-05-27 | Intimation Of Book Closure For Payment Of Final Dividend For Fy 2025 | - |
| 2026-05-27 | Intimation Of 3Rd Annual General Meeting Of The Company | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹3,752.70, within a 52-week range of ₹3,752.70 to ₹5,026.80. The P/E ratio is 34.43 and the P/B ratio is 26.33, with earnings per unit of ₹104.27. Market capitalisation stands at ₹8,905.94 Cr and the dividend yield is 1.88%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.